About this Journal Submit a Manuscript Table of Contents
ISRN Urology
Volume 2012 (2012), Article ID 252846, 5 pages
http://dx.doi.org/10.5402/2012/252846
Clinical Study

The Correlation between Diffusion-Weighted Imaging and Histopathological Evaluation of 356 Prostate Biopsy Sites in Patients with Prostatic Diseases

1Department of Urology, II Clinic, Ankara Numune Education and Research Hospital, Ankara, Turkey
2Department of Radiology, I Clinic, Ankara Numune Education and Research Hospital, Ankara, Turkey
3Department of Urology, I Clinic, Ankara Numune Education and Research Hospital, Ankara, Turkey

Received 29 March 2012; Accepted 7 May 2012

Academic Editors: A. M. El-Assmy and A. Papatsoris

Copyright © 2012 R. Kilinç et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. L. Parker, T. Tong, S. Bolden, and P. A. Wingo, “Cancer statistics, 1997,” CA Cancer Journal for Clinicians, vol. 47, no. 1, pp. 5–27, 1997. View at Scopus
  2. B. A. Wilkinson and F. C. Hamdy, “State-of-the-art staging in prostate cancer,” BJU International, vol. 87, no. 5, pp. 423–430, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. M. K. Brawer, “Prostate-specific antigen: current status,” CA Cancer Journal for Clinicians, vol. 49, no. 5, pp. 264–281, 1999. View at Scopus
  4. C. R. Pound, A. W. Partin, J. I. Epstein, and P. C. Walsh, “Prostate-specific antigen after anatomic radical retropubic prostatectomy: patterns of recurrence and cancer control,” Urologic Clinics of North America, vol. 24, no. 2, pp. 395–406, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Tanimoto, J. Nakashima, H. Kohno, H. Shinmoto, and S. Kuribayashi, “Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging,” Journal of Magnetic Resonance Imaging, vol. 25, no. 1, pp. 146–152, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Kumar, N. R. Jagannathan, R. Kumar et al., “Apparent diffusion coefficient of the prostate in men prior to biopsy: determination of a cut-off value to predict malignancy of the peripheral zone,” NMR in Biomedicine, vol. 20, no. 5, pp. 505–511, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Kajihara, Y. Hayashida, R. Murakami et al., “Usefulness of diffusion-weighted imaging in the localization of prostate cancer,” International Journal of Radiation Oncology Biology Physics, vol. 74, no. 2, pp. 399–403, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. Ö. Kılıçkesmez, T. Cimilli, E. İnci et al., “Diffusion-weighted MRI of urinary bladder and prostate cancers,” Diagnostic and Interventional Radiology, vol. 15, no. 2, pp. 104–110, 2009. View at Scopus
  9. I. M. Thompson, D. K. Pauler, P. J. Goodman et al., “Prevalence of prostate cancer among men with a prostate-specific antigen level 4 ng per milliliter,” The New England Journal of Medicine, vol. 350, no. 22, pp. 2239–2246, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. J. P. Richie, W. J. Catalona, F. R. Ahmann et al., “Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination,” Urology, vol. 42, no. 4, pp. 365–374, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. H. B. Carter and W. Partin, “Diagnosis and Staging of prostate Cancer,” in Campbell’s Urology, P. C. Walsh, A. B. Retik, A. J. Wein, and E. D. Vaughan, Eds., pp. 3055–3079, Elsevier Saunders, Philadelphia, Pa, USA, 8th edition, 2002.
  12. Y. J. Choi, J. K. Kim, N. Kim, W. K. Kim, E. K. Choi, and K. S. Cho, “Functional MR imaging of prostate cancer,” Radiographics, vol. 27, no. 1, pp. 63–75, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Hosseinzadeh and S. D. Schwarz, “Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue,” Journal of Magnetic Resonance Imaging, vol. 20, no. 4, pp. 654–661, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Sato, S. Naganawa, T. Nakamura et al., “Differentiation of noncancerous tissue and cancer lesion by apparent diffusion coefficient values in transition and peripheral zones of the prostate,” Journal of Magnetic Resonance Imaging, vol. 21, no. 3, pp. 258–262, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Issa, “In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging,” Journal of Magnetic Resonance Imaging, vol. 16, no. 2, pp. 196–200, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Tamada, T. Sone, Y. Jo et al., “Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade,” Journal of Magnetic Resonance Imaging, vol. 28, no. 3, pp. 720–726, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Yoshimitsu, K. Kiyoshima, H. Irie et al., “Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology,” Journal of Magnetic Resonance Imaging, vol. 27, no. 1, pp. 132–139, 2008. View at Publisher · View at Google Scholar · View at Scopus